Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$303M |
| 2 |
General Dynamics
GD
|
+$147M |
| 3 |
Cigna
CI
|
+$95.5M |
| 4 |
CVS Health
CVS
|
+$85.5M |
| 5 |
Marathon Petroleum
MPC
|
+$52.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AET
Aetna Inc
AET
|
+$234M |
| 2 |
Northrop Grumman
NOC
|
+$218M |
| 3 |
ESRX
Express Scripts Holding Company
ESRX
|
+$170M |
| 4 |
PX
Praxair Inc
PX
|
+$168M |
| 5 |
COL
Rockwell Collins
COL
|
+$116M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.9% |
| 2 | Healthcare | 16.26% |
| 3 | Consumer Discretionary | 11.53% |
| 4 | Communication Services | 10.15% |
| 5 | Industrials | 9.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MDCO
1426
DELISTED
Medicines Co
MDCO
| $2.5M | ﹤0.01% |
130,450
+2,100
| +2% | +$48.9K |
|
1427
Compass Minerals
CMP
$1.12B
| $2.5M | ﹤0.01% |
59,850
+900
| +2% | +$47.4K |
|
|
TEN
1428
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
| $2.49M | ﹤0.01% |
90,900
+1,100
| +1% | +$36.8K |
|
1429
Bloomin' Brands
BLMN
$975M
| $2.49M | ﹤0.01% |
139,100
+3,100
| +2% | +$61.1K |
|
|
MIME
1430
DELISTED
Mimecast Limited
MIME
| $2.48M | ﹤0.01% |
+73,900
| New | +$2.58M |
|
|
MGLN
1431
DELISTED
Magellan Health Services, Inc.
MGLN
| $2.47M | ﹤0.01% |
43,400
+400
| +0.9% | +$24.7K |
|
1432
Corcept Therapeutics
CORT
$12.1B
| $2.47M | ﹤0.01% |
184,700
+5,800
| +3% | +$76.7K |
|
|
MTOR
1433
DELISTED
MERITOR, Inc.
MTOR
| $2.46M | ﹤0.01% |
145,600
| – | – |
|
|
MIK
1434
DELISTED
Michaels Stores, Inc
MIK
| $2.46M | ﹤0.01% |
181,843
-7,500
| -4% | -$119K |
|
|
ECOL
1435
DELISTED
US Ecology, Inc.
ECOL
| $2.45M | ﹤0.01% |
38,900
+600
| +2% | +$40.3K |
|
|
GHDX
1436
DELISTED
Genomic Health, Inc.
GHDX
| $2.45M | ﹤0.01% |
38,000
+1,700
| +5% | +$119K |
|
|
SUM
1437
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $2.45M | ﹤0.01% |
200,714
+3,458
| +2% | +$47.8K |
|
|
MANT
1438
DELISTED
Mantech International Corp
MANT
| $2.44M | ﹤0.01% |
46,687
+700
| +2% | +$39.3K |
|
1439
Werner Enterprises
WERN
$2.31B
| $2.43M | ﹤0.01% |
82,300
+600
| +0.7% | +$19.6K |
|
1440
Employers Holdings
EIG
$864M
| $2.43M | ﹤0.01% |
57,900
+1,600
| +3% | +$70.2K |
|
1441
Kulicke & Soffa
KLIC
$4.98B
| $2.42M | ﹤0.01% |
119,500
-4,200
| -3% | -$87K |
|
1442
Vanda Pharmaceuticals
VNDA
$314M
| $2.42M | ﹤0.01% |
92,600
+3,600
| +4% | +$84.6K |
|
1443
HUTCHMED
HCM
$2.13B
| $2.41M | ﹤0.01% |
+104,287
| New | +$3.24M |
|
|
HTLF
1444
DELISTED
Heartland Financial USA, Inc.
HTLF
| $2.41M | ﹤0.01% |
54,800
+6,000
| +12% | +$314K |
|
1445
Abercrombie & Fitch
ANF
$4.99B
| $2.4M | ﹤0.01% |
119,900
+1,800
| +2% | +$33.7K |
|
|
NSU
1446
DELISTED
Nevsun Resources Ltd.
NSU
| $2.4M | ﹤0.01% |
546,800
+11,000
| +2% | +$48.8K |
|
1447
Asbury Automotive
ABG
$3.76B
| $2.4M | ﹤0.01% |
36,000
-400
| -1% | -$26.3K |
|
|
APTI
1448
DELISTED
Apptio, Inc. Class A Common Stock
APTI
| $2.4M | ﹤0.01% |
+63,100
| New | +$2.13M |
|
1449
Hilltop Holdings
HTH
$2.25B
| $2.39M | ﹤0.01% |
134,200
| – | – |
|
1450
Pricesmart
PSMT
$5.49B
| $2.39M | ﹤0.01% |
40,400
+700
| +2% | +$48.2K |
|
Similar funds
Swiss National Bank's Q4 2018 Portfolio in Review
As of Q4 2018, Swiss National Bank held 2,591 positions worth $78B, down 13% from $89.8B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Swiss National Bank's Q4 2018 filing shows 87 new, 1,610 increased, 323 reduced and 55 closed positions. Its largest new stake was Linde: 1,915,836 shares worth $299M. The largest sale was Aetna Inc, an estimated $234M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Swiss National Bank's largest Q4 2018 buy was Linde: 1,915,836 shares worth $299M.
- Swiss National Bank added most to Cigna in Q4 2018, an estimated $95.5M increase.
- Swiss National Bank's biggest Q4 2018 reduction was Dell, cutting an estimated $52.3M.
- Swiss National Bank fully exited Aetna Inc in Q4 2018, selling an estimated $234M.
- Swiss National Bank's ten largest holdings make up 18% of its $78B portfolio in Q4 2018.
- Swiss National Bank opened 87 new positions and closed 55 in Q4 2018.
- Swiss National Bank's portfolio value fell 13% quarter-over-quarter to $78B.
Based on Swiss National Bank's 13F filing for Q4 2018, filed 13 Feb 2019.